L3VLUP
ProSign in

GMAB · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

GMABLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • GMAB
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterGMABLLY
Q3 20207 holders, $364m33 holders, $14.1bn
Q4 20205 holders, $238m29 holders, $17.3bn
Q1 20213 holders, $121m24 holders, $23.0bn
Q2 20213 holders, $187m24 holders, $27.8bn
Q3 20213 holders, $166m31 holders, $29.9bn
Q4 20213 holders, $168m31 holders, $34.7bn
Q1 20224 holders, $168m24 holders, $35.3bn
Q2 20224 holders, $96m33 holders, $42.7bn
Q3 20227 holders, $412m31 holders, $43.4bn
Q4 20226 holders, $422m31 holders, $46.6bn
Q1 20233 holders, $333m33 holders, $44.3bn
Q2 20232 holders, $343m37 holders, $59.6bn
Q3 20233 holders, $385m44 holders, $67.6bn
Q4 20234 holders, $548m45 holders, $73.6bn
Q1 20246 holders, $540m41 holders, $95.3bn
Q2 20246 holders, $457m43 holders, $110bn
Q3 20246 holders, $447m45 holders, $107bn
Q4 20248 holders, $480m46 holders, $93.9bn
Q1 20258 holders, $495m42 holders, $98.4bn
Q2 202510 holders, $495m43 holders, $93.2bn
Q3 20257 holders, $643m39 holders, $86.7bn
Q4 20255 holders, $617m41 holders, $123bn
Q1 20266 holders, $623m39 holders, $106bn
Q2 20267 holders, $583m44 holders, $132bn
GMAB

Genmab A S

Holders
4
Reported value
$548m
Buyers
4
Sellers
0

Breadth +4 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
LLY

Eli Lilly & Co

Holders
45
Reported value
$73.6bn
Buyers
27
Sellers
21

Breadth +6 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2023

Among the 46 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only GMAB (1)

Baillie Gifford & Co

Only LLY (42)

Acadian Asset Management LLC, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Holocene Advisors LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, Maverick Capital Ltd, MFS Investment Management, Millennium Management LLC, and 17 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →